{
    "organizations": [],
    "uuid": "9715c07449efb4c4cfb46bae32628f08bfecc178",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-clovis-oncology-files-prospectus-s/brief-clovis-oncology-files-prospectus-supplement-related-to-offering-200-mln-principal-amount-of-convertible-senior-notes-idUSFWN1RT09K",
    "ord_in_thread": 0,
    "title": "BRIEF-Clovis Oncology Files Prospectus Supplement Related To Offering $200 Mln Principal Amount Of Convertible Senior Notes",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - Clovis Oncology Inc:\n* CLOVIS ONCOLOGY INC FILES PROSPECTUS SUPPLEMENT RELATED TO OFFERING $200 MILLION PRINCIPAL AMOUNT OF CONVERTIBLE SENIOR NOTES DUE 2025 - SEC FILING Source text: ( bit.ly/2qzin28 ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-16T18:48:00.000+03:00",
    "crawled": "2018-04-17T12:17:24.018+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "clovis",
        "oncology",
        "inc",
        "clovis",
        "oncology",
        "inc",
        "file",
        "prospectus",
        "supplement",
        "related",
        "offering",
        "million",
        "principal",
        "amount",
        "convertible",
        "senior",
        "note",
        "due",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}